Update: Feedback on SAHPRA’s EOIs and latest appointments
The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of...
21 February, 25The South African Health Products Regulatory Authority (SAHPRA) has published four (4) Expression of...
21 February, 25Cairo, Egypt, 4 February 2025: The Africa Centres for Disease Control and Prevention (Africa CDC) an...
05 February, 25Pretoria – The leading agencies, the South African Health Products Regulatory Authority (SAHPR...
04 February, 25Pretoria, 17 January 2025 – The South African Health Products Regulatory Authority (SAHPRA) has reco...
17 January, 25There have been several cases around the world in which Tranexamic acid has been administered intrat...
21 December, 23The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal...
19 October, 21In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20SAHPRA alerts all healthcare professionals about the risk of serious heart problems, seizures, coma ...
01 November, 20An out-of-specification result for related substances observed during stability testing of batch GH21051.
An inadvertent inclusion of plasma from an unapproved supplier in the formulation, which was not detected at the time of batch release.
The recall is initiated because some units of the batch presented with low fill volumes, and therefore does not meet the final product specifications with respect to the volume.